KAILERA
Live / Allowed — Notice of allowance issued (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98773333
- Mark type
- Word mark
- Filed
- 27 Sept 2024
- Published for opposition
- 18 Nov 2025
- Attorney of record
- Gabriel M. Gillmeyer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of metabolic and endocrine diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the fields of metabolic science and endocrine science
Owner
- Kailera Therapeutics, Inc., Waltham, MA, US
- Kailera Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 20 Jan 2026 — CASE ASSIGNED TO TTAB
- 20 Jan 2026 — NOTICE OF ALLOWANCE CANCELLED
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Dec 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Apr 2025 — NON-FINAL ACTION E-MAILED